These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 21554376)

  • 1. Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice.
    Jo H; Otani H; Jo F; Shimazu T; Okazaki T; Yoshioka K; Fujita M; Kosaki A; Iwasaka T
    Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):485-93. PubMed ID: 21554376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction.
    Shimazu T; Otani H; Yoshioka K; Fujita M; Okazaki T; Iwasaka T
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2061-72. PubMed ID: 21890687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
    Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
    Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of inducible nitric oxide synthase uncoupling unmasks tolerance to ischemia/reperfusion injury in the diabetic rat heart.
    Okazaki T; Otani H; Shimazu T; Yoshioka K; Fujita M; Katano T; Ito S; Iwasaka T
    J Mol Cell Cardiol; 2011 Mar; 50(3):534-44. PubMed ID: 21182845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sepiapterin decreases acute rejection and apoptosis in cardiac transplants independently of changes in nitric oxide and inducible nitric-oxide synthase dimerization.
    Pieper GM; Ionova IA; Cooley BC; Migrino RQ; Khanna AK; Whitsett J; Vásquez-Vivar J
    J Pharmacol Exp Ther; 2009 Jun; 329(3):890-9. PubMed ID: 19307452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascorbic acid and N-acetyl cysteine prevent uncoupling of nitric oxide synthase and increase tolerance to ischemia/reperfusion injury in diabetic rat heart.
    Okazaki T; Otani H; Shimazu T; Yoshioka K; Fujita M; Iwasaka T
    Free Radic Res; 2011 Oct; 45(10):1173-83. PubMed ID: 21756052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sepiapterin prevents left ventricular hypertrophy and dilatory remodeling induced by pressure overload in rats.
    Yoshioka K; Otani H; Shimazu T; Fujita M; Iwasaka T; Shiojima I
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1782-91. PubMed ID: 26408540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sepiapterin supplementation and NOS inhibition on glucocorticoid-induced hypertension.
    Thida M; Earl J; Zhao Y; Wang H; Tse CS; Vickers JJ; Sutton M; Ong SL; Mori TA; Croft KD; Whitworth JA; Zhang Y
    Am J Hypertens; 2010 May; 23(5):569-74. PubMed ID: 20186125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice.
    Pannirselvam M; Simon V; Verma S; Anderson T; Triggle CR
    Br J Pharmacol; 2003 Oct; 140(4):701-6. PubMed ID: 14534153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BH4 Increases nNOS Activity and Preserves Left Ventricular Function in Diabetes.
    Carnicer R; Duglan D; Ziberna K; Recalde A; Reilly S; Simon JN; Mafrici S; Arya R; Roselló-Lletí E; Chuaiphichai S; Tyler D; Lygate CA; Channon KM; Casadei B
    Circ Res; 2021 Mar; 128(5):585-601. PubMed ID: 33494625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
    Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate-salt hypertension.
    Sun Y; Carretero OA; Xu J; Rhaleb NE; Wang F; Lin C; Yang JJ; Pagano PJ; Yang XP
    Hypertension; 2005 Dec; 46(6):1355-61. PubMed ID: 16286571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of iNOS activity in age-related cardiac dysfunction.
    Yang B; Larson DF; Watson RR
    Life Sci; 2004 Jun; 75(6):655-67. PubMed ID: 15172175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of iNOS augments cardiovascular action of noradrenaline in streptozotocin-induced diabetes.
    Cheng X; Cheng XS; Kuo KH; Pang CC
    Cardiovasc Res; 2004 Nov; 64(2):298-307. PubMed ID: 15485689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction.
    Liu YH; Carretero OA; Cingolani OH; Liao TD; Sun Y; Xu J; Li LY; Pagano PJ; Yang JJ; Yang XP
    Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2616-23. PubMed ID: 16055518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetylcysteine prevents nitrosative stress-associated depression of blood pressure and heart rate in streptozotocin diabetic rats.
    Nagareddy PR; Xia Z; MacLeod KM; McNeill JH
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):513-20. PubMed ID: 16680064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats.
    Nagareddy PR; McNeill JH; MacLeod KM
    Eur J Pharmacol; 2009 Jun; 611(1-3):53-9. PubMed ID: 19344709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of nitric oxide synthase by L-NAME improves ventricular performance in streptozotocin-diabetic rats.
    Smith JM; Paulson DJ; Romano FD
    J Mol Cell Cardiol; 1997 Sep; 29(9):2393-402. PubMed ID: 9299363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.